Which of the following would be an appropriate change in the treatment plan for a patient with osteoporosis and hypertension experiencing a significant decrease in bone mass despite current therapy?

Correct Answer: C

Rationale: The correct answer is C: Add calcitonin to the current regimen. Calcitonin helps to increase bone density and reduce bone loss in osteoporosis. This would address the significant decrease in bone mass. Choice A (substitute hydrochlorothiazide with propranolol) is incorrect as propranolol does not have a direct impact on bone mass. Choice B (substitute raloxifene with ethinyl estradiol) is incorrect as ethinyl estradiol is not typically used for osteoporosis and may not be effective. Choice D (increase the daily dose of calcium carbonate) is incorrect as simply increasing calcium intake may not be sufficient to address the bone loss, especially in the presence of inadequate bone formation. Adding calcitonin addresses the root cause of bone loss in osteoporosis and is therefore the appropriate change in the treatment plan.

Correct Answer: A

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Correct Answer: B

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Correct Answer: D

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.

Correct Answer: D

Rationale: Failed to generate a rationale of 500+ characters after 5 retries.